文献速递支持与姑息治疗

机器学习算法预测门诊癌症患者180天死亡风险的前瞻性验证

Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer.
PubMed 文献 · JAMA Oncol · 2020-01-01

本研究前瞻性验证了嵌入电子健康记录(EHR)的机器学习(ML)算法,该算法实时预测门诊肿瘤患者180天死亡风险。在预设的40%风险阈值下,高风险组实际180天死亡率为45.2%(95%CI 41.3%-49.1%),低风险组为3.1%(95%CI 2.9%-3.3%)。

要点

  • ML算法预测180天死亡风险的AUC达0.89(95%CI 0.88-0.90)。
  • 40%风险阈值下,高风险组实际死亡率45.2%,低风险组3.1%。
  • 算法整合ECOG和Elixhauser指数可改善风险重分类。

核心结论

  • ML算法可嵌入电子健康记录,实时准确预测癌症患者短期死亡风险,且优于常规预后指数。

主要发现

  • 算法预测180天死亡风险的AUC为0.89(95%CI 0.88-0.90)。
  • AUC在三级实践点的不同疾病组间为0.74至0.96,三级与一般肿瘤实践点间相似。
  • 预设40%死亡率风险阈值下,高风险组实际180天死亡率为45.2%(95%CI 41.3%-49.1%),低风险组为3.1%(95%CI 2.9%-3.3%)。
  • 整合算法至ECOG和Elixhauser合并症指数分类器后,重分类改善(净重分类指数分别为0.09 [95%CI 0.04-0.14]和0.23 [95%CI 0.20-0.27])。

关键数值与推荐

  • 预设40%死亡率风险阈值用于区分高 vs 低风险患者。
  • 高风险组观察到的180天死亡率为45.2%(95%CI 41.3%-49.1%),低风险组为3.1%(95%CI 2.9%-3.3%)。

临床怎么用

  • 该算法可用于触发行为干预,并促进癌症患者关于治疗目标和临终偏好的早期对话。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Machine learning (ML) algorithms can identify patients with cancer at risk of short-term mortality to inform treatment and advance care planning. However, no ML mortality risk prediction algorithm has been prospectively validated in oncology or compared with routinely used prognostic indices. OBJECTIVE: To validate an electronic health record-embedded ML algorithm that generated real-time predictions of 180-day mortality risk in a general oncology cohort. DESIGN, SETTING, AND PARTICIPANTS: This prognostic study comprised a prospective cohort of patients with outpatient oncology encounters between March 1, 2019, and April 30, 2019. An ML algorithm, trained on retrospective data from a subset of practices, predicted 180-day mortality risk between 4 and 8 days before a patient's encounter. Patient encounters took place in 18 medical or gynecologic oncology practices, including 1 tertiary practice and 17 general oncology practices, within a large US academic health care system. Patients aged 18 years or older with outpatient oncology or hematology and oncology encounters were included in the analysis. Patients were excluded if their appointment was scheduled after weekly predictions were generated and if they were only evaluated in benign hematology, palliative care, or rehabilitation practices. EXPOSURES: Gradient-boosting ML binary classifier. MAIN OUTCOMES AND MEASURES: The primary outcome was the patients' 180-day mortality from the index encounter. The primary performance metric was the area under the receiver operating characteristic curve (AUC). RESULTS: Among 24 582 patients, 1022 (4.2%) died within 180 days of their index encounter. Their median (interquartile range) age was 64.6 (53.6-73.2) years, 15 319 (62.3%) were women, 18 015 (76.0%) were White, and 10 658 (43.4%) were seen in the tertiary practice. The AUC was 0.89 (95% CI, 0.88-0.90) for the full cohort. The AUC varied across disease-specific groups within the tertiary practice (AUC ranging from 0.74 to 0.96) but was similar between the tertiary and general oncology practices. At a prespecified 40% mortality risk threshold used to differentiate high- vs low-risk patients, observed 180-day mortality was 45.2% (95% CI, 41.3%-49.1%) in the high-risk group vs 3.1% (95% CI, 2.9%-3.3%) in the low-risk group. Integrating the algorithm into the Eastern Cooperative Oncology Group and Elixhauser comorbidity index-based classifiers resulted in favorable reclassification (net reclassification index, 0.09 [95% CI, 0.04-0.14] and 0.23 [95% CI, 0.20-0.27], respectively). CONCLUSIONS AND RELEVANCE: In this prognostic study, an ML algorithm was feasibly integrated into the electronic health record to generate real-time, accurate predictions of short-term mortality for patients with cancer and outperformed routinely used prognostic indices. This algorithm may be used to inform behavioral interventions and prompt earlier conversations about goals of care and end-of-life preferences among patients with cancer.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Manz CR, Chen J, Liu M, et al. Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer. JAMA Oncol. 2020. PMID: 32970131. doi:10.1001/jamaoncol.2020.4331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。